61 related articles for article (PubMed ID: 19302923)
1. Upregulation of plasma CCL8 in mouse model of graft-vs-host disease.
Ota A; Yamamoto M; Hori T; Miyai S; Naishiro Y; Sohma H; Maeda M; Kokai Y
Exp Hematol; 2009 Apr; 37(4):525-31. PubMed ID: 19302923
[TBL] [Abstract][Full Text] [Related]
2. Early expression of plasma CCL8 closely correlates with survival rate of acute graft-vs.-host disease in mice.
Yamamoto M; Ota A; Hori T; Imai S; Sohma H; Suzuki N; Hatakeyama N; Inazawa N; Ito YM; Kimura H; Tsutsumi H; Kokai Y
Exp Hematol; 2011 Nov; 39(11):1101-12. PubMed ID: 21782767
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of Tripterygium hypoglaucum (level) Hutch on preventing acute graft-versus-host disease in bone marrow transplantation mice].
Li S; Xu KL; Li ZY; Pan XY; Sun HY; Li DP; Cao J; Du B
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):727-30. PubMed ID: 18457261
[TBL] [Abstract][Full Text] [Related]
4. CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease.
Hori T; Naishiro Y; Sohma H; Suzuki N; Hatakeyama N; Yamamoto M; Sonoda T; Mizue Y; Imai K; Tsutsumi H; Kokai Y
Blood; 2008 Apr; 111(8):4403-12. PubMed ID: 18256320
[TBL] [Abstract][Full Text] [Related]
5. A murine model of graft-vs-host disease after in utero hematopoietic cell transplantation.
Misra MV; Gutweiler JR; Suh MY; Twark CM; Valim C; Perez-Atayde A; Kim HB
J Pediatr Surg; 2009 Jun; 44(6):1102-7; discussion 1107. PubMed ID: 19524724
[TBL] [Abstract][Full Text] [Related]
6. CCL8 deficiency in the host abrogates early mortality of acute graft-versus-host disease in mice with dysregulated IL-6 expression.
Igarashi K; Hori T; Yamamoto M; Sohma H; Suzuki N; Tsutsumi H; Kawasaki Y; Kokai Y
Exp Hematol; 2022 Feb; 106():47-57. PubMed ID: 34808257
[TBL] [Abstract][Full Text] [Related]
7. Synergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effects.
Struyf S; Proost P; Vandercappellen J; Dempe S; Noyens B; Nelissen S; Gouwy M; Locati M; Opdenakker G; Dinsart C; Van Damme J
Eur J Immunol; 2009 Mar; 39(3):843-57. PubMed ID: 19224633
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
9. Severe graft versus host disease in a patient with globoid cell leukodystrophy following umbilical cord blood transplantation: resemblance to the twitcher mouse model.
Ozen M; Uçkan D; Cetin M; Tezcan I; Tuncer M; Anlar B
Turk J Pediatr; 2007; 49(3):304-6. PubMed ID: 17990586
[TBL] [Abstract][Full Text] [Related]
10. Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras.
de Jager SC; Canté-Barrett K; Bot I; Husberg C; van Puijvelde GH; van Santbrink PJ; Yndestad A; van den Oever JM; Kuiper J; van Berkel TJ; Lipp M; Zwaginga JJ; Fibbe WE; Aukrust P; Biessen EA
Transplantation; 2009 Sep; 88(5):631-9. PubMed ID: 19741459
[TBL] [Abstract][Full Text] [Related]
11. Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells.
Islam SA; Chang DS; Colvin RA; Byrne MH; McCully ML; Moser B; Lira SA; Charo IF; Luster AD
Nat Immunol; 2011 Feb; 12(2):167-77. PubMed ID: 21217759
[TBL] [Abstract][Full Text] [Related]
12. Determination of human transferrin concentrations in mouse models of neisserial infection.
Perera Y; Cobas K; Garrido Y; Nazabal C; Brown E; Pajon R
J Immunol Methods; 2006 Apr; 311(1-2):153-63. PubMed ID: 16529768
[TBL] [Abstract][Full Text] [Related]
13. Stromal cell-derived CXCL12 and CCL8 cooperate to support increased development of regulatory dendritic cells following Leishmania infection.
Nguyen Hoang AT; Liu H; Juaréz J; Aziz N; Kaye PM; Svensson M
J Immunol; 2010 Aug; 185(4):2360-71. PubMed ID: 20624948
[TBL] [Abstract][Full Text] [Related]
14. Hair growth after GVHD induction in BALB/c nude mice.
Morita H; Kitano Y
Bone Marrow Transplant; 1995 Dec; 16(6):857-8. PubMed ID: 8750285
[No Abstract] [Full Text] [Related]
15. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
[TBL] [Abstract][Full Text] [Related]
16. Estrogenic effects of monocrotophos evaluated by vitellogenin mRNA and protein induction in male goldfish (Carassius auratus).
Tian H; Ru S; Wang Z; Cai W; Wang W
Comp Biochem Physiol C Toxicol Pharmacol; 2009 Aug; 150(2):231-6. PubMed ID: 19439194
[TBL] [Abstract][Full Text] [Related]
17. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.
Pozo D; Anderson P; Gonzalez-Rey E
J Immunol; 2009 Oct; 183(7):4346-59. PubMed ID: 19734220
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
[TBL] [Abstract][Full Text] [Related]
19. Development of a biomarker assay for 3-indoxyl sulfate in mouse plasma and brain by liquid chromatography/tandem mass spectrometry.
Wang G; Korfmacher WA
Rapid Commun Mass Spectrom; 2009 Jul; 23(13):2061-9. PubMed ID: 19504476
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
